Help appealing denials for this transcatheter mitral valve replacement for inoperable patients.

Appeal Your Edwards SAPIEN M3 Denial

Get access to this first transfemoral mitral valve replacement.

Understanding Your Edwards SAPIEN M3 TMVR System Denial

The Edwards SAPIEN M3 is the first transcatheter mitral valve replacement (TMVR) system approved for patients with symptomatic moderate-to-severe mitral regurgitation who cannot undergo traditional surgery. This represents a breakthrough for patients with no other options. Insurance may require documentation of surgical ineligibility.

Common Reasons for Denial

  • ! Prior authorization required
  • ! Surgical candidacy not adequately ruled out
  • ! Imaging requirements not met
  • ! Must try MitraClip or other repair first
  • ! Facility/center not approved
  • ! New technology coverage limitations

How We Help

We help you document your mitral regurgitation severity, symptoms, heart team evaluation, reasons for surgical ineligibility, and why TMVR is your best option.

Some Types of Evidence We Can Use For Supporting Your Appeal

SAPIEN M3 is the first transcatheter mitral valve replacement approved for transfemoral delivery.

Clinical trials demonstrated significant reduction in mitral regurgitation and improvement in symptoms.

Transcatheter options provide treatment for patients who previously had no surgical options.

Heart team evaluation is essential for determining appropriate patient selection.

Patient Advocacy & Support Organizations

These organizations provide education, support, and advocacy for patients:

American Heart Association

Leading nonprofit fighting heart disease through education, advocacy, and research.

Mended Hearts

Peer support network for heart patients and their families.

Frequently Asked Questions

SAPIEN M3 is for patients with symptomatic moderate-to-severe mitral regurgitation who are at prohibitive risk for surgical mitral valve replacement or repair, as determined by a heart team.

Include your surgical risk assessment (STS score), heart team evaluation notes, comorbidities that increase surgical risk, and any prior cardiac surgeries that complicate reoperation.

Ready to Fight Your Edwards SAPIEN M3 TMVR System Denial?

Our free AI-powered tool will help you generate a compelling appeal letter in minutes.

Disclaimer: Fight Health Insurance is not affiliated with, endorsed by, or partnered with any pharmaceutical manufacturer, healthcare provider, medical device company, or patient assistance program, including Edwards Lifesciences. All information provided is for educational and informational purposes only and does not constitute medical or legal advice. Please consult with your healthcare provider regarding treatment options and with your insurance company regarding coverage decisions.